[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fzXkqaOmvQnujjagSY2MMB_IY9JHR4FHNDp72QVKFOjo":3},{"categories":4,"category":21,"news":23,"page":61},[5,9,13,17],{"_id":6,"slug":7,"title":8},"9d24481e-11aa-4c59-8771-36db00e91a2e","nerve-repair","Nerve repair",{"_id":10,"slug":11,"title":12},"c098646c-9061-4278-96a9-6a3e9a140b5a","events","Events",{"_id":14,"slug":15,"title":16},"d5f23208-d5ad-4b48-a510-a5616e101bb2","general","General",{"_id":18,"slug":19,"title":20},"df73f049-cea5-413c-866f-c6dbc8f4183c","silkbridge","SILKBridge",{"_id":14,"seo":22,"slug":15,"title":16},null,[24,30,38,47,53],{"_id":25,"category":26,"content":22,"date":27,"heroImage":22,"slug":28,"title":29},"169b176d-5255-46a7-9c7c-a805e8837ef7",{"_id":14,"slug":15,"title":16},"2024-02-28T00:00:00.000Z","klisbio-secures-euro25-million-grant-eic-accelerator-program-propel-growth-europe","KLISBio Secures €2.5 Million Grant by the EIC Accelerator Program to Propel Growth in Europe",{"_id":31,"category":32,"content":33,"date":27,"heroImage":34,"slug":36,"title":37},"5eeea3c4-7a72-4c33-8d14-ef03bed13d13",{"_id":14,"slug":15,"title":16},"KLISBio, a MedTech company advancing regenerative medicine through a silk-based technology platform, has announced receipt of a grant from the EIC Accelerator Program administered by the European Innovation Council and SMEs Executive Agency (EISMEA). The €2.5 million in non-dilutive funding recognizes KLISBio's innovative contributions to the MedTech sector.",{"altText":22,"ref":35},"image-9592d780933d8d2e041204ec12a11b87ab884084-2000x3000-jpg","klisbio-ottiene-euro25m-da-eic-accelerator-program-per-supportare-la-crescita-aziendale-europa","KLISBio ottiene €2,5M da EIC Accelerator Program per supportare la crescita aziendale in Europa",{"_id":39,"category":40,"content":41,"date":42,"heroImage":43,"slug":45,"title":46},"de1a8a8f-98df-4bf5-9e59-81824f2a5641",{"_id":14,"slug":15,"title":16},"Great ideas often emerge from unexpected circumstances and intuition, yet transforming them into reality demands commitment, expertise, and a skilled team. Silk Biomaterials, now operating as KLISBio, resulted from a fortuitous meeting among four professionals — Antonio Alessandrino, Giuliano Freddi, Gabriele Grecchi, and Lorenzo Sala — united by a shared mission to enhance human wellbeing.","2022-05-13T00:00:00.000Z",{"altText":22,"ref":44},"image-abab23660edc7139c3fc7ad6efb1fa35bcfb3ba3-2000x1353-jpg","klisbio-2022-company-history","KLISBio, Company history",{"_id":48,"category":49,"content":22,"date":50,"heroImage":22,"slug":51,"title":52},"4f34aa77-5901-4e2e-8bb7-5d24cb7279b5",{"_id":14,"slug":15,"title":16},"2022-01-12T00:00:00.000Z","klisbio-new-chairman","KLISBio appoints Rodrigo Bianchi as new Chairman of the Board",{"_id":54,"category":55,"content":22,"date":56,"heroImage":57,"slug":59,"title":60},"59f57d17-dec7-405a-a1da-1e8d0bfe3f27",{"_id":14,"slug":15,"title":16},"2022-01-11T00:00:00.000Z",{"altText":22,"ref":58},"image-1faed57f9577986b1ca68963ee46f563cf23b514-2000x1125-jpg","silk-biomaterials-rebranding-klisbio","Silk Biomaterials ushers in the next evolution of life sciences innovation with rebranding and new name",{"_id":62,"content":63,"title":64},"newsPage","Explore the latest news from KLISBio®, from company updates and scientific advancements to product milestones, events, and key announcements.","News"]